New England Journal of Medicine published a clinical update in Research Highlights on 18 Feb 2026. The item focuses on Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Review the original article for the full source wording and details.
New England Journal of Medicine published a clinical update in Research Highlights on 18 Feb 2026.
The item focuses on Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
Review the original article for the full source wording and details.